J&J’s Consumer Sales Buoyed By Listerine In Third Quarter
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's Listerine mouthwash brand achieved double-digit growth in its most recent quarter, fueled by international sales and the recent U.S. launch of Whitening Quick Dissolving Strips, the firm said Oct. 16
You may also be interested in...
Johnson & Johnson Starts Downsizing Plan, PCH Integration Stays On Track
Johnson & Johnson executives are touting the strength of the firm's consumer products businesses as they implement a plan to generate up to $1.6 billion in savings through consolidations and layoffs in J&J's pharmaceutical and medical device operations
J&J, Pfizer Satisfy FTC Conditions To Clear Deal; EC Signs Off
Johnson & Johnson and Pfizer's divestiture of the Zantac, Cortizone, Unisom and Balmex brands satisfies the Federal Trade Commission's anticompetitive complaint about J&J's acquisition of Pfizer's consumer healthcare business
SafetyCall On What Cosmetics Companies Need In Their AE Reporting Systems
Companies preparing for adverse event reporting and recordkeeping deadlines on 29 December under new cosmetics regulations should ensure they have systems in place for netting complaints across media, triaging reports, and making speedy weight-of-evidence determinations, said SafetyCall International’s Rick Kingston at IBA’s recent FDA regulatory workshop.